Deutsche Bank
FBRX

Deutsche Bank’s Forte Biosciences FBRX Stock Holding History

Deutsche Bank’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
+19,271
New +$457K ﹤0.01% 2877
2022
Q2 		– Sell
-1,451
Closed -$53K – 4188
2022
Q1 		$53K Sell
1,451
-1,111
-43% -$42K ﹤0.01% 3820
2021
Q4 		$137K Buy
2,562
+2,235
+683% +$150K ﹤0.01% 3559
2021
Q3 		$24K Sell
327
-87
-21% -$48.2K ﹤0.01% 4216
2021
Q2 		$348K Buy
414
+288
+229% +$260K ﹤0.01% 3459
2021
Q1 		$108K Hold
126
– – ﹤0.01% 3935
2020
Q4 		$114K Hold
126
– – ﹤0.01% 3778
2020
Q3 		$152K Sell
126
-9
-7% -$5.97K ﹤0.01% 3353
2020
Q2 		$49K Sell
135
-9
-6% -$4.02K ﹤0.01% 3832
2020
Q1 		$66K Sell
144
-73
-34% -$28.5K ﹤0.01% 3420
2019
Q4 		$42K Sell
217
-212
-49% -$48K ﹤0.01% 4038
2019
Q3 		$105K Sell
429
-249
-37% -$378K ﹤0.01% 3520
2019
Q2 		$1.7M Buy
678
+527
+349% +$1.56M ﹤0.01% 2506
2019
Q1 		$612K Buy
151
+94
+165% +$363K ﹤0.01% 3323
2018
Q4 		$174K Sell
57
-81
-59% -$349K ﹤0.01% 3949
2018
Q3 		$805K Buy
138
+33
+31% +$126K ﹤0.01% 3488
2018
Q2 		$369K Buy
105
+37
+54% +$135K ﹤0.01% 3997
2018
Q1 		$302K Sell
68
-47
-41% -$218K ﹤0.01% 3981
2017
Q4 		$440K Buy
115
+95
+475% +$379K ﹤0.01% 3672
2017
Q3 		$93K Sell
20
-8
-29% -$35.6K ﹤0.01% 4189
2017
Q2 		$126K Buy
+28
New +$158K ﹤0.01% 4126

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Deutsche Bank's FBRX Position: Q2 2026 in Review

Deutsche Bank opened a new position in Forte Biosciences (FBRX) in Q2 2026: 19,271 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #2877 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in FBRX as recently as Q1 2022.

Deutsche Bank first reported a position in FBRX in Q2 2017 and has held it in 21 quarters since. The position peaked at $1.7M in Q2 2019. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Deutsche Bank held 19,271 shares of Forte Biosciences worth $410K as of Q2 2026.
  • Forte Biosciences was a new Deutsche Bank position in Q2 2026.
  • Forte Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2877 holding.
  • Deutsche Bank first reported a position in Forte Biosciences in Q2 2017 and has held it in 21 quarters since.
  • Deutsche Bank's Forte Biosciences position peaked at $1.7M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.